Hostname: page-component-586b7cd67f-dlnhk Total loading time: 0 Render date: 2024-11-25T20:11:18.818Z Has data issue: false hasContentIssue false
  • English
  • Français

Diazepam, Propranolol and their Combination in the Management of Chronic Anxiety

Published online by Cambridge University Press:  29 January 2018

C. Hallstrom ,
I. Treasaden ,
J. Guy Edwards  and
M. Lader
C. Hallstrom
Affiliation:
Institute of Psychiatry, Department of Pharmacology, De Crespigny Park, Denmark Hill, London SE5 8AF
I. Treasaden
Affiliation:
University of Southampton Medical School, Royal South Hants Hospital, Southampton SO9 4PE
J. Guy Edwards
Affiliation:
Royal South Hants Hospital, Southampton SO9 4PE
M. Lader
Affiliation:
Institute of Psychiatry, Department of Pharmacology, De Crespigny Park, Denmark Hill, London SE5 8AF
Get access Rights & Permissions [Opens in a new window]

Summary

The therapeutic benefit of combining propranolol with diazepam over either of these drugs given alone was tested in a placebo-controlled crossover study with twenty-four chronically anxious out-patients. The combination was generally more effective than diazepam. Diazepam was more effective than placebo or propranolol. A reduction in the resting pulse rate by propranolol of more than 7.5 beats per minute resulted in a greater therapeutic response to this drug, alone and in combination. Lesser degrees of pathology responded better to treatment. Psychological factors in treatment showed themselves to be important in moderating pharmacological response. Chronically anxious patients generally derived little benefit from continued anti-anxiety treatment.

Type
Research Article
Information
The British Journal of Psychiatry , Volume 139 , Issue 5 , November 1981 , pp. 417 - 421
Copyright
Copyright © Royal College of Psychiatrists, 1981 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Brown, G. W. & Birley, J. L. T. (1968) Crises and life changes and the arrest of schizophrenia. Journal of Health and Social Behaviour, 9, 203–14.CrossRefGoogle Scholar
Covi, L., Lipman, R., Pallison, J., Derogate, L. & Uhlenhuth, E. (1973) Length of treatment with anxiolytic sedatives and response to their sudden withdrawal. Acta Psychiatrica Scandinavica, 49, 51—64.CrossRefGoogle ScholarPubMed
Edwards, J. G., Alexander, J. R., Alexander, M. S., Gordon, A. & Zutchi, T. (1980) Controlled trial of sulpiride in chronic schizophrenic patients. British Journal of Psychiatry, 137, 522–9.CrossRefGoogle ScholarPubMed
Hallstrom, C. & Lader, M. H. (1981) Benzodiazepine withdrawal phenomena. International Pharmacopsychiatry, in press.CrossRefGoogle Scholar
Hamilton, M. (1959) The assessment of anxiety states by rating. British Journal of Medical Psychology, 32, 50–5.CrossRefGoogle ScholarPubMed
Granville-Grossman, K. L. & Turner, P. (1966) The effect of propranolol on anxiety. Lancet, i, 788–90.Google Scholar
Salkind, M. (1973) The construction and validation of a self-rating anxiety inventory. Ph.D. Thesis. University of London.Google Scholar
Shader, R. I., Good, M. I. & Greenblatt, D. J. (1976) Progress in Psychiatric Drug Treatment. Vol. 2. (Eds. Klein, D. F. and Gittelman-Klein, R.), pp 509–28. New York: Brunner Mazel.Google Scholar
Tyrer, P. (1980) Use of β-blocking drugs in psychiatry and neurology. Drugs, 20, 300–8.CrossRefGoogle ScholarPubMed
Tyrer, P. & Lader, M. H. (1974a) Response to propranolol and diazepam in somatic and psychic anxiety. British Medical Journal, ii, 14—16.CrossRefGoogle Scholar
Tyrer, P. & Lader, M. H. (1974b) Physiological and psychological effects of +/- propranolol, propranolol and diazepam in anxiety. British Journal of Clinical Pharmacology, 1, 379–85.Google Scholar
Submit a response

eLetters

No eLetters have been published for this article.